About Yokohama City Minato Red Cross Hospital
Clinical Trials at Yokohama City Minato Red Cross Hospital
During the past decade, Yokohama City Minato Red Cross Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Yokohama City Minato Red Cross Hospital" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials
sponsored, "AstraZeneca" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Boston Scientific Corporation"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Yokohama City Minato Red Cross Hospital"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Yokohama City Minato Red Cross Hospital
According to Clinical.Site data, the most researched conditions in "Yokohama City Minato Red Cross Hospital" are
"Asthma" (2 trials), "Atopic Dermatitis" (2 trials), "Atrial Fibrillation" (2 trials), "Alzheimer Disease" (1 trials) and "Central Neuropathic Pain" (1 trials). Many other conditions were trialed in "Yokohama City Minato Red Cross Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Yokohama City Minato Red Cross Hospital
Most popular intervention types in "Yokohama City Minato Red Cross Hospital" are "Drug" (8 trials) and "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (2 trials), "Arctic Front Advance Cardiac CryoAblation Catheter" (1 trials), "BAY1817080" (1 trials) and "Boston Scientific Cardiac Cryoablation System" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Yokohama City Minato Red Cross Hospital
The vast majority of trials in "Yokohama City Minato Red Cross Hospital" are
13 trials for "All" genders.
Clinical Trials Status at Yokohama City Minato Red Cross Hospital
Currently, there are NaN active trials in "Yokohama City Minato Red Cross Hospital".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Yokohama City Minato Red Cross Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Yokohama City Minato Red Cross Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".